QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 19, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Acute Kidney InjuryAcute Kidney Injury Due to Sepsis
Interventions
DEVICE

QUELIMMUNE (SCD-PED)

QUELIMMUNE device used as part of clinical practice.

Trial Locations (9)

19104

NOT_YET_RECRUITING

Children's Hospital of Philadelphia, Philadelphia

35233

RECRUITING

Children's of Alabama, Birmingham

45229

RECRUITING

Cincinnati Children's Hospital, Cincinnati

48109

NOT_YET_RECRUITING

CS Mott Children's Hospital, Ann Arbor

60611

RECRUITING

Lurie Children's Hospital of Chicago, Chicago

76104

RECRUITING

Cook Children's Hospital, Fort Worth

77030

RECRUITING

Texas Children's Hospital, Houston

94304

RECRUITING

Lucile Packard Children's Hospital Stanford, Palo Alto

94618

RECRUITING

UCSF Benioff Children's, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SeaStar Medical

INDUSTRY

NCT06517810 - QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry | Biotech Hunter | Biotech Hunter